Vilastobart in combination with atezolizumab continued to demonstrate a differentiated and generally well-tolerated safety profile. Treatment-related adverse events (AEs) were primarily Grade 1 or 2, ...
The Promega OncoMate® MSI Dx Analysis System has received FDA approval as a companion diagnostic for KEYTRUDA® plus LENVIMA® ...
Globalstar’s XCOM RAN brings a software-defined approach to the IT/OT challenge in Industry 4.0, via an open RAN private 5G ...
Record bookings growth for SonicWall’s strategic solutions highlights SonicWall’s evolution into a full-scale cybersecurity leader and trusted managed services partner.
Detailed price information for Maison Solutions Inc Cl A (MSS-Q) from The Globe and Mail including charting and trades.
ORR in heavily pre-treated patients with MSS mCRC without liver metastases and with high plasma tumor mutational burden (TMB) ...
Captain feels other elements equal, or even more important with Blues off to rough start despite numbers saying they should ...
Preclinical data support best-in-class potential of masked T cell engager programs and platform utilizing Xilio’s ATACR and SEECR formats, ...
NIMS has been developing chemical sensors as a key component of artificial olfaction technology (olfactory sensors), with the ...
This study presents valuable findings on the role of KLF6 in in vitro endothelial cells exposed to altered (high or low) shear stress with a customized microfluidic device to investigate mechanisms of ...
ExlService Holdings reported strong third quarter 2025 results with revenue rising to US$529.59 million and net income reaching US$58.16 million, while management also raised full-year financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback